Insider Trading By Ex-FDA Official Puts Spotlight On Current Agency Practices
This article was originally published in The Pink Sheet Daily
Executive Summary
After Office of Generic Drugs Deputy Director Gordon Johnston left FDA, he joined GPhA and 'tricked' a former colleague into sharing info on generic Lovenox on behalf of a hedge fund he was secretly working for, SEC says.